U.S., AstraZeneca Strike Deal For COVID-19 Antibody Treatment Touted By Trump

The U.S. government has awarded $486 million to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID19 antibody treatment, a similar class of drug that was used in treating President Donald Trump.

from Top Business News- News18.com